THERESA BANMEKE: Open Payments
NPI 1861125197 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $459 · 2025 $939
Food & beverage: $939
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $232 |
| Cipher Pharmaceuticals US LLC | 1 | $154 |
| Gilead Sciences, Inc. | 1 | $128 |
| GlaxoSmithKline, LLC. | 1 | $123 |
| Janssen Pharmaceuticals, Inc | 1 | $111 |
| Neurelis, Inc. | 1 | $101 |
| Phathom Pharmaceuticals, Inc. | 1 | $89 |
Products named: Natroba, Descovy, AREXVY, FASENRA, SPRAVATO, VALTOCO, VOQUEZNA.
Industry payments across PA — which companies pay providers there.
